Antioxidant effects of Carvedilol and Alluporinol in patients with diabetes type II; A randomized, double-blind placebo-controlled clinical trial

被引：0
|
作者：
Larijani, B
Afshari, M
Mojtahedi, A
Astanehi-Asghari, F
Hossein-Nezhad, A
Heshmat, R
Rezaie, A
Zamani, MJ
Mostafalou, S
Abdollahi, M
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A513 / A513
页数：1
相关论文
共 50 条
  • [1] Creatine in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Gualano, Bruno
    Painneli, Vitor De Salles
    Roschel, Hamilton
    Artioli, Guilherme Giannini
    Neves, Manoel, Jr.
    De Sa Pinto, Ana Lucia
    Rossi Da Silva, Maria Elizabeth
    Cunha, Maria Rosaria
    Garcia Otaduy, Maria Concepcion
    Leite, Claudia Da Costa
    Ferreira, Julio Cesar
    Pereira, Rosa Maria
    Brum, Patricia Chakur
    Bonfa, Eloisa
    Lancha, Antonio Herbert, Jr.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (05): : 770 - 778
  • [2] The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Seyyedebrahimi, ShadiSadat
    Khodabandehloo, Hadi
    Esfahani, Ensieh Nasli
    Meshkani, Reza
    ACTA DIABETOLOGICA, 2018, 55 (04) : 341 - 353
  • [3] The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    ShadiSadat Seyyedebrahimi
    Hadi Khodabandehloo
    Ensieh Nasli Esfahani
    Reza Meshkani
    Acta Diabetologica, 2018, 55 : 341 - 353
  • [4] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [5] Correction to: The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    ShadiSadat Seyyedebrahimi
    Hadi Khodabandehloo
    Ensieh Nasli Esfahani
    Reza Meshkani
    Acta Diabetologica, 2018, 55 : 1087 - 1087
  • [6] The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial
    Najafipour, Mostafa
    Najafipour, Farzad
    Ostadrahimi, Alireza
    Ghavami, Maryam
    Razaghi, Zohreh
    Tutunchi, Helda
    Alamdari, Naimeh Mesri
    HEALTH PROMOTION PERSPECTIVES, 2024, 14 (04): : 380 - 387
  • [7] Dilated cardiomyopathy in dialysis patients - Beneficial effects of carvedilol: A double-blind, placebo-controlled trial
    Cice, G
    Ferrara, L
    Di Benedetto, A
    Russo, PE
    Marinelli, G
    Pavese, F
    Iacono, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 407 - 411
  • [8] Effects of the Lysulin™ supplementation on pre-diabetes: A randomized double-blind, placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Jayawardena, Ranil
    Chandrasena, Lal
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1479 - 1486
  • [9] Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial
    Lustman, PJ
    Freedland, KE
    Griffith, LS
    Clouse, RE
    DIABETES CARE, 2000, 23 (05) : 618 - 623
  • [10] Effects of Probiotics in Patients with Diabetes Mellitus Type 2: A Study Protocol for a Randomized, Double-blind, Placebo-controlled Trial
    Sabico, Shaun
    Alokail, Majed
    Al-Daghri, Nasser
    McTernan, Philip
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 : S230 - S230
12345